Evaluation of Peripheral EOS for the Peripheral Embolization Treatment to Rapidly OccluDe Venous or Arterial BleEding

NCT02033954 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2015-06-24

No results posted yet for this study

Summary

To collect confirmatory data in support of the safety and performance of the ArtVentive Medical Group Endoluminal Occlusion System.

Conditions

Sponsors & Collaborators

  • ArtVentive Medical Group, Inc.

    lead INDUSTRY

Principal Investigators

  • Andreas Mahnken, Prof Dr · Universitätsklinikum Giessen und Marburg (UKGM) Klinik für diagnostische und

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-12-31
Completion
2016-01-31

Countries

  • Austria
  • Belgium
  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02033954 on ClinicalTrials.gov